Signature Gyn Services

1. GlaxoSmithKline, LLC. $134,733 80 payments
2. Organon LLC $123,616 57 payments
3. Bayer HealthCare Pharmaceuticals Inc. $80,335 20 payments
4. Exeltis, USA Inc. $73,780 44 payments
5. Astellas Pharma Global Development $54,270 38 payments
6. Teva Pharmaceuticals USA, Inc. $39,860 10 payments
7. Merck Sharp & Dohme Corporation $30,451 4 payments

1. A Descriptive, Prospective, Multi-Country, Multicentre Study to Assess $90,378 68 payments
2. BAY1454032 Essure System for Permanent Birth Control $73,928 14 payments
3. A Phase 3, Open-label, Multi-center, Single Arm Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel MK-8415 Implant During Extended Use From 3 Years After Insertion in Females 35 Years of Age or Younger $55,852 40 payments
4. A Phase IV, Longitudinal, Observational Study Examining Real-World Outcomes of Non-Hormonal Pharmacotherapies Among Individuals Treated for Bothersome Vasomotor Symptoms $54,270 38 payments
5. Study name not reported $44,355 12 payments
6. A Randomized, Double-Blind, Placebo-Controlled, Parallel- Design, Multiple-Site Study to Evaluate the Therapeutic Equivalence of Estradiol Vaginal Inserts 4 mcg (Teva Pharmaceuticals, Inc.) With IMVEXXY (Estradiol Vaginal Inserts) (TherapeuticsMD, Inc.) in the Treatment of Dyspareunia in Women With Vulvar and Vaginal Atrophy $39,860 10 payments
7. LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women $36,157 24 payments
8. 8415-8415-060-PN060-Extended Duration Study (Celanese + 2 years)-Contraception-SC-imp-Supplemental Registration-USA-LD-B $30,941 1 payment
9. Efficacy and Safety of Nexplanon 36 to 60 Months Post Insertion $29,816 9 payments
10. LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women $27,487 8 payments

1. Patient care $123,616 57 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.